Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Karp

Showing results (341-350 of 397) with videos related to

Pageof 40
Sort By:
Nature Biomedical Engineering|August 9, 2019
A resistance-sensing mechanical injector for the precise delivery of liquids to target tissueGirish D Chitnis, Mohan K S Verma, Julien Lamazouade, et al.
Blood|October 29, 2011
Engineered cell homingDebanjan Sarkar, Joel A Spencer, Joseph A Phillips, et al.
Nature Communications|January 12, 2022
Robust differentiation of human enteroendocrine cells from intestinal stem cellsDaniel Zeve, Eric Stas, Joshua de Sousa Casal, et al.
Bioorganic & Medicinal Chemistry Letters|December 15, 2015
Discovery of 2-(4-sulfonamidophenyl)-indole 3-carboxamides as potent and selective inhibitors with broad hepatitis C virus genotype activity targeting HCV NS4BNanjing Zhang, Anthony Turpoff, Xiaoyan Zhang, et al.
Nano Letters|July 10, 2012
Tracking mesenchymal stem cells with iron oxide nanoparticle loaded poly(lactide-co-glycolide) microparticlesChenjie Xu, David Miranda-Nieves, James A Ankrum, et al.
Science Advances|August 25, 2020
Shattering barriers toward clinically meaningful MSC therapiesOren Levy, Rui Kuai, Erika M J Siren, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|January 23, 2008
An inhibitor of methionine aminopeptidase type-2, PPI-2458, ameliorates the pathophysiological disease processes of rheumatoid arthritisD D Lazarus, E G Doyle, S G Bernier, et al.
Stem Cells Translational Medicine|February 9, 2019
A Phase I Study to Assess the Safety and Cancer-Homing Ability of Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells in Men with Localized Prostate CancerMichael T Schweizer, Hao Wang, Trinity J Bivalacqua, et al.
Blood|August 28, 2013
mRNA-engineered mesenchymal stem cells for targeted delivery of interleukin-10 to sites of inflammationOren Levy, Weian Zhao, Luke J Mortensen, et al.
Molecular Cancer Therapeutics|December 5, 2020
Cabozantinib Unlocks Efficient <i>In Vivo</i> Targeted Delivery of Neutrophil-Loaded Nanoparticles into Murine Prostate TumorsKiranj Kishor Chaudagar, Natalie Landon-Brace, Aniruddh Solanki, et al.
Pageof 40

Showing results (341-350 of 397) with videos related to

Sort By:
Pageof 40
Nature Biomedical Engineering|August 9, 2019
A resistance-sensing mechanical injector for the precise delivery of liquids to target tissueGirish D Chitnis, Mohan K S Verma, Julien Lamazouade, et al.
Blood|October 29, 2011
Engineered cell homingDebanjan Sarkar, Joel A Spencer, Joseph A Phillips, et al.
Nature Communications|January 12, 2022
Robust differentiation of human enteroendocrine cells from intestinal stem cellsDaniel Zeve, Eric Stas, Joshua de Sousa Casal, et al.
Bioorganic & Medicinal Chemistry Letters|December 15, 2015
Discovery of 2-(4-sulfonamidophenyl)-indole 3-carboxamides as potent and selective inhibitors with broad hepatitis C virus genotype activity targeting HCV NS4BNanjing Zhang, Anthony Turpoff, Xiaoyan Zhang, et al.
Nano Letters|July 10, 2012
Tracking mesenchymal stem cells with iron oxide nanoparticle loaded poly(lactide-co-glycolide) microparticlesChenjie Xu, David Miranda-Nieves, James A Ankrum, et al.
Science Advances|August 25, 2020
Shattering barriers toward clinically meaningful MSC therapiesOren Levy, Rui Kuai, Erika M J Siren, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|January 23, 2008
An inhibitor of methionine aminopeptidase type-2, PPI-2458, ameliorates the pathophysiological disease processes of rheumatoid arthritisD D Lazarus, E G Doyle, S G Bernier, et al.
Stem Cells Translational Medicine|February 9, 2019
A Phase I Study to Assess the Safety and Cancer-Homing Ability of Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells in Men with Localized Prostate CancerMichael T Schweizer, Hao Wang, Trinity J Bivalacqua, et al.
Blood|August 28, 2013
mRNA-engineered mesenchymal stem cells for targeted delivery of interleukin-10 to sites of inflammationOren Levy, Weian Zhao, Luke J Mortensen, et al.
Molecular Cancer Therapeutics|December 5, 2020
Cabozantinib Unlocks Efficient <i>In Vivo</i> Targeted Delivery of Neutrophil-Loaded Nanoparticles into Murine Prostate TumorsKiranj Kishor Chaudagar, Natalie Landon-Brace, Aniruddh Solanki, et al.
Pageof 40